|
Amicus Therapeutics Commences Phase 1/2 Study of Novel ERT for Treatment of Pompe Disease
|
Amicus |
|
The Swiss Pompe Group
|
Caspar Kemper |
|
Pompe Registry - A Decade of Making a Difference
|
Webmaster |
|
2015 AMDA International Pompe Patient and Scientific Conference - Summary Report
|
Allan Muir |
|
#AMDAIPA Pompe Conference on Twitter
|
Webmaster |
|
Australia has admitted life-saving drug for Pompe disease in the Australian Life-Saving Drug Programme
|
IPA |
|
Visit to the World War II Commemoration Monument in Saint Pancras (The Netherlands)
|
Maryze and Tiffany |
|
Registration is now open for the 2015 International Pompe Patient and Scientific Conference
|
IPA |
|
Genzyme Pompe Community Program Update
|
Genzyme |
|
Amicus Therapeutics Honors Fabry Disease Awareness Month and International Pompe Day
|
Amicus |
